ArticleFrontiers in oncology2024

Lorlatinib in the treatment of a rare pulmonary mucoepidermoid carcinoma with EML4-ALK fusion: a case report and literature review.

Zijun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.